Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix

Focal Adhesion Kinase (FAK) is an important regulator of tumor cell proliferation, survival and metastasis. As such it has become a therapeutic target of interest in cancer. Previous studies suggested that use of FAK tyrosine kinase inhibitors (TKIs) blocks osteolysis in in vivo models of bone metas...

Full description

Bibliographic Details
Main Authors: Scott A. Gunn, Lauren M. Kreps, Huijun Zhao, Katelyn Landon, Jacob S. Ilacqua, Christina L. Addison
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of Bone Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137422000227